The South Korean units of McDonald's, Burger King, and KFC are facing growing skepticism over finding new owners for their franchises here, due to increased difficulties in fundraising and a growing preference among domestic consumers for healthier foods.
According to a food and beverage franchise buyout expert, the pool of buyers who can afford higher prices has become smaller because interest rate hikes have worsened the condition of the acquisition financing market.
He added that the chains' valuations will also be impacted by the concurrent sales attempts.
To avoid harsher market conditions next year, Korean fast-food franchise owners must sell their businesses this year.
Fast food restaurants face significant risks from rising labor and ingredient expenses because it is challenging to raise prices to cover these costs.
The snowballing losses in the fried chicken and hamburger business cost KFC's Korean operator KG Group, which led to a capital impairment in 2020.
KG Group is reportedly desperate to sell the KFC franchise for about 100 billion won, to secure enough cash to buy SsangYong Motor.
Following a failed attempt in 2016, McDonald's US headquarters launched another attempt to sell its Korean business.
However, prospective buyers objected to the conditions of the deal.
Operating losses for McDonald's Korea amounted to 44 billion won in 2019, 48,3 billion won in 2020, and 27.7 billion won in 2021.
The operator of Burger King's Korean location, Affinity Equity Partners, is thought to be more in need of a quick sale because it is a PEF and is required to quickly sell its portfolio companies to disperse profits to its investors.
The Hong Kong-based PEF has been attempting to sell the Burger King's Korean unit in 2016 and its Japanese counterpart for a combined 1 trillion won since late last year.
Insiders in the M&A market, however, expressed doubt about the hamburger business being purchased by a PEF and noted that it will be challenging to increase its valuation until divestiture.


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 



